| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (30 ug) then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
rod electrophysiology trait |
both |
87.0 days
| 5 |
83.0 |
uV |
7.0 |
15.65 |
electroretinography |
cornea |
0.0 |
plasmid delivery |
71 |
days |
pVAX2-rGDNF |
scotopic b-wave ERG |
108735 |
3131 |
| RCS-p+/LavRrrc |
scotopic A wave amplitude of ERG waveform |
sham gene transfer using an empty plasmid vector pVAX2 (30 ug) then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
rod electrophysiology trait |
both |
87.0 days
| 5 |
24.5 |
uV |
4.9 |
10.96 |
electroretinography |
cornea |
0.0 |
plasmid delivery |
71 |
days |
|
scotopic a-wave ERG |
108734 |
3131 |
| RCS-p+/LavRrrc |
retinal outer nuclear layer photoreceptor nucleus count to layer length ratio |
control condition |
Kang S, et al., Transl Vis Sci Technol. 2019 Aug 7;8(4):19. doi: 10.1167/tvst.8.4.19. eCollection 2019 Jul. |
retinal photoreceptor quantity |
not specified |
180.0 days
| 5 |
3.3 |
/ 100 um |
2.8 |
6.26 |
ex vivo light microscopy with histochemistry |
|
0.0 |
|
|
|
contralateral control eye |
|
107362 |
3082 |
| RCS-p+/LavRrrc |
retinal outer nuclear layer photoreceptor nucleus count to layer length ratio |
laser photocoagulation (225 um) (for 0 hours) |
Kang S, et al., Transl Vis Sci Technol. 2019 Aug 7;8(4):19. doi: 10.1167/tvst.8.4.19. eCollection 2019 Jul. |
retinal photoreceptor quantity |
not specified |
180.0 days
| 5 |
2.1 |
/ 100 um |
1.9 |
4.25 |
ex vivo light microscopy with histochemistry |
|
0.0 |
photocoagulation |
161 |
days |
experimental eye |
|
107371 |
3082 |
| RCS-p+/LavRrrc |
retinal outer nuclear layer photoreceptor nucleus count to layer length ratio |
control condition |
Kang S, et al., Transl Vis Sci Technol. 2019 Aug 7;8(4):19. doi: 10.1167/tvst.8.4.19. eCollection 2019 Jul. |
retinal photoreceptor quantity |
not specified |
180.0 days
| 5 |
1.8 |
/ 100 um |
1.9 |
4.25 |
ex vivo light microscopy with histochemistry |
|
0.0 |
|
|
|
contralateral control eye |
|
107372 |
3082 |
| RCS-p+/LavRrrc |
scotopic A wave amplitude of ERG waveform |
control condition then controlled exposure to darkness (for 12 hours) |
Tao Z, et al., Oncotarget. 2016 Aug 2;7(31):49368-49383. doi: 10.18632/oncotarget.10343. |
rod electrophysiology trait |
both |
34.0 days
| 8 |
13.0 |
uV |
13.0 |
36.77 |
electroretinography |
|
0.0 |
|
|
|
untreated control |
electrical activity measurement of retina (CMO:0003653)/A wave |
108374 |
3121 |
| RCS-p+/LavRrrc |
scotopic A wave amplitude of ERG waveform |
control condition then controlled exposure to darkness (for 12 hours) |
Tao Z, et al., Oncotarget. 2016 Aug 2;7(31):49368-49383. doi: 10.18632/oncotarget.10343. |
rod electrophysiology trait |
both |
48.0 days
| 5 |
17.0 |
uV |
5.0 |
11.18 |
electroretinography |
|
0.0 |
|
|
|
untreated control |
a-wave amplitude ERG |
108380 |
3121 |
| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
gene transfer of the enhanced green fluorescent protein gene using an adenovirus vector (5250000 PFU) then controlled exposure to darkness (for 12 hours) |
Tao Z, et al., Oncotarget. 2016 Aug 2;7(31):49368-49383. doi: 10.18632/oncotarget.10343. |
rod electrophysiology trait |
both |
48.0 days
| 5 |
51.0 |
uV |
33.0 |
73.79 |
electroretinography |
cornea |
0.0 |
subretinal injection |
28 |
days |
adenovirus |
b-wave amplitude ERG |
108384 |
3121 |
| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
control condition then controlled exposure to darkness (for 12 hours) |
Tao Z, et al., Oncotarget. 2016 Aug 2;7(31):49368-49383. doi: 10.18632/oncotarget.10343. |
rod electrophysiology trait |
both |
62.0 days
| 5 |
13.0 |
uV |
17.0 |
38.01 |
electroretinography |
|
0.0 |
|
|
|
untreated control |
b-wave amplitude ERG |
108389 |
3121 |
| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
sham gene transfer using an empty plasmid vector pVAX2 (30 ug) then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
rod electrophysiology trait |
both |
53.0 days
| 5 |
352.0 |
uV |
26.0 |
58.14 |
electroretinography |
cornea |
0.0 |
plasmid delivery |
37 |
days |
|
scotopic b-wave ERG |
108701 |
3131 |
| RCS-p+/LavRrrc |
retinal inner nuclear layer thickness |
gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (30 ug) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
retinal inner nuclear layer morphology trait |
both |
51.0 days
| 5 |
26.3 |
um |
1.5 |
3.35 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
plasmid delivery |
35 |
days |
pVAX2-rGDNF |
retinal inner nuclear layer thickness (CMO:0003668) |
108707 |
3131 |
| RCS-p+/LavRrrc |
retinal inner nuclear layer thickness |
sham gene transfer using an empty plasmid vector pVAX2 (30 ug) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
retinal inner nuclear layer morphology trait |
both |
51.0 days
| 5 |
19.6 |
um |
0.5 |
1.12 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
plasmid delivery |
35 |
days |
|
retinal inner nuclear layer thickness (CMO:0003668) |
108708 |
3131 |
| RCS-p+/LavRrrc |
photoreceptor inner segment thickness |
gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (30 ug) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
photoreceptor inner segment morphology trait |
both |
51.0 days
| 5 |
8.1 |
um |
0.4 |
0.89 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
plasmid delivery |
35 |
days |
pVAX2-rGDNF |
superior hemisphere - photoreceptor IS |
108711 |
3131 |
| RCS-p+/LavRrrc |
photoreceptor inner segment thickness |
gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (15 ug) and gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (15 ug) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
photoreceptor inner segment morphology trait |
both |
70.0 days
| 4 |
8.3 |
um |
1.7 |
3.4 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
plasmid delivery |
54 |
days |
pVAX2-rGDNF |
superior hemisphere |
108744 |
3131 |
| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
sham gene transfer using an empty plasmid vector pVAX2 (30 ug) and sham gene transfer using an empty plasmid vector pVAX2 (30 ug) then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
rod electrophysiology trait |
both |
70.0 days
| 3 |
231.0 |
uV |
5.0 |
8.66 |
electroretinography |
cornea |
0.0 |
plasmid delivery |
54 |
days |
pVAX2 |
scotopic b-wave ERG |
108749 |
3131 |
| RCS-p+/LavRrrc |
debris zone thickness |
light phase of controlled light/dark cycle (0-5 lux) (for 12 hours) |
Bubis E, et al., Transl Vis Sci Technol. 2019 Feb 28;8(1):26. doi: 10.1167/tvst.8.1.26. eCollection 2019 Jan. |
retinal photoreceptor layer morphology trait |
not specified |
42.0 days
| 18 |
44.4 |
um |
0.6 |
2.55 |
optical coherence tomography |
retina |
0.0 |
|
|
|
Heidelberg Spectralis SD-OCT |
debris zone |
110660 |
3181 |
| RCS-p+/LavRrrc |
debris zone thickness |
light phase of controlled light/dark cycle (0-5 lux) (for 12 hours) |
Bubis E, et al., Transl Vis Sci Technol. 2019 Feb 28;8(1):26. doi: 10.1167/tvst.8.1.26. eCollection 2019 Jan. |
retinal photoreceptor layer morphology trait |
not specified |
56.0 days
| 15 |
36.6 |
um |
1.0 |
3.87 |
optical coherence tomography |
retina |
0.0 |
|
|
|
Heidelberg Spectralis SD-OCT |
debris zone |
110661 |
3181 |
| RCS-p+/LavRrrc |
full retina thickness |
light phase of controlled light/dark cycle (0-5 lux) (for 12 hours) |
Bubis E, et al., Transl Vis Sci Technol. 2019 Feb 28;8(1):26. doi: 10.1167/tvst.8.1.26. eCollection 2019 Jan. |
retinal layer morphology trait |
not specified |
70.0 days
| 12 |
163.7 |
um |
1.8 |
6.24 |
optical coherence tomography |
retina |
0.0 |
|
|
|
Heidelberg Spectralis SD-OCT |
|
110667 |
3181 |
| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (30 ug) then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
rod electrophysiology trait |
both |
53.0 days
| 5 |
475.0 |
uV |
41.0 |
91.68 |
electroretinography |
cornea |
0.0 |
plasmid delivery |
37 |
days |
pVAX2-rGDNF |
scotopic b-wave ERG |
108727 |
3131 |
| RCS-p+/LavRrrc |
scotopic A wave amplitude of ERG waveform |
2-methyl-6-(phenylethynyl)pyridine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2)) |
Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. |
rod electrophysiology trait |
both |
39.0 days
| 7 |
33.73 |
uV |
9.28 |
24.55 |
electroretinography |
cornea |
0.0 |
subretinal injection |
4 |
days |
MPEP |
a-wave amplitude ERG |
108540 |
3123 |
| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
2-methyl-6-(phenylethynyl)pyridine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2)) |
Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. |
rod electrophysiology trait |
both |
39.0 days
| 7 |
192.0 |
uV |
14.42 |
38.15 |
electroretinography |
cornea |
0.0 |
subretinal injection |
4 |
days |
pbs |
a wave amplitude ERG |
108545 |
3123 |
| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
2-methyl-6-(phenylethynyl)pyridine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2)) |
Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. |
rod electrophysiology trait |
both |
39.0 days
| 7 |
233.29 |
uV |
18.61 |
49.24 |
electroretinography |
cornea |
0.0 |
subretinal injection |
4 |
days |
pbs |
a wave amplitude ERG |
108546 |
3123 |
| RCS-p+/LavRrrc |
scotopic A wave amplitude of ERG waveform |
phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2)) |
Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. |
rod electrophysiology trait |
both |
39.0 days
| 7 |
19.05 |
uV |
3.75 |
9.92 |
electroretinography |
cornea |
0.0 |
subretinal injection |
4 |
days |
MPEP |
a-wave amplitude ERG |
108550 |
3123 |
| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2)) |
Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. |
rod electrophysiology trait |
both |
39.0 days
| 7 |
159.83 |
uV |
21.35 |
56.49 |
electroretinography |
cornea |
0.0 |
subretinal injection |
4 |
days |
pbs |
b-wave amplitude ERG |
108558 |
3123 |
| RCS-p+/LavRrrc |
retinal outer nuclear layer photoreceptor nucleus count to layer length ratio |
control condition |
Kang S, et al., Transl Vis Sci Technol. 2019 Aug 7;8(4):19. doi: 10.1167/tvst.8.4.19. eCollection 2019 Jul. |
retinal photoreceptor quantity |
not specified |
180.0 days
| 5 |
2.4 |
/ 100 um |
3.2 |
7.16 |
ex vivo light microscopy with histochemistry |
|
0.0 |
|
|
|
contralateral control eye |
|
107364 |
3082 |
| RCS-p+/LavRrrc |
retinal outer nuclear layer photoreceptor nucleus count to layer length ratio |
control condition |
Kang S, et al., Transl Vis Sci Technol. 2019 Aug 7;8(4):19. doi: 10.1167/tvst.8.4.19. eCollection 2019 Jul. |
retinal photoreceptor quantity |
not specified |
180.0 days
| 5 |
3.5 |
/ 100 um |
3.0 |
6.71 |
ex vivo light microscopy with histochemistry |
|
0.0 |
|
|
|
contralateral control eye |
|
107370 |
3082 |
| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
control condition then controlled exposure to darkness (for 12 hours) |
Tao Z, et al., Oncotarget. 2016 Aug 2;7(31):49368-49383. doi: 10.18632/oncotarget.10343. |
rod electrophysiology trait |
both |
34.0 days
| 8 |
45.0 |
uV |
42.0 |
118.79 |
electroretinography |
|
0.0 |
|
|
|
untreated control |
b-wave amplitude ERG |
108377 |
3121 |
| RCS-p+/LavRrrc |
scotopic A wave amplitude of ERG waveform |
gene transfer of the enhanced green fluorescent protein gene using an adenovirus vector (5250000 PFU) then controlled exposure to darkness (for 12 hours) |
Tao Z, et al., Oncotarget. 2016 Aug 2;7(31):49368-49383. doi: 10.18632/oncotarget.10343. |
rod electrophysiology trait |
both |
48.0 days
| 5 |
17.0 |
uV |
18.0 |
40.25 |
electroretinography |
cornea |
0.0 |
subretinal injection |
28 |
days |
adenovirus |
a-wave amplitude ERG |
108381 |
3121 |
| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
gene transfer of the enhanced green fluorescent protein gene using an adenovirus vector (5250000 PFU) then controlled exposure to darkness (for 12 hours) |
Tao Z, et al., Oncotarget. 2016 Aug 2;7(31):49368-49383. doi: 10.18632/oncotarget.10343. |
rod electrophysiology trait |
both |
62.0 days
| 5 |
14.0 |
uV |
17.0 |
38.01 |
electroretinography |
cornea |
0.0 |
subretinal injection |
42 |
days |
adenovirus |
b-wave amplitude ERG |
108390 |
3121 |
| RCS-p+/LavRrrc |
scotopic A wave amplitude of ERG waveform |
2-methyl-6-(phenylethynyl)pyridine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2)) |
Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. |
rod electrophysiology trait |
both |
39.0 days
| 7 |
11.45 |
uV |
3.56 |
9.42 |
electroretinography |
cornea |
0.0 |
subretinal injection |
4 |
days |
MPEP |
a-wave amplitude ERG |
108537 |
3123 |
| RCS-p+/LavRrrc |
retinal inner nuclear layer thickness |
control condition |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
retinal inner nuclear layer morphology trait |
both |
75.0 days
| 3 |
25.1 |
um |
1.3 |
2.25 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
55 |
days |
control for age matched plasmid injection |
|
108698 |
3131 |
| RCS-p+/LavRrrc |
retinal outer nuclear layer thickness |
sham gene transfer using an empty plasmid vector pVAX2 (30 ug) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
retinal outer nuclear layer morphology trait |
both |
75.0 days
| 5 |
14.4 |
um |
1.5 |
3.35 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
plasmid delivery |
55 |
days |
|
|
108699 |
3131 |
| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
control condition then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
rod electrophysiology trait |
both |
53.0 days
| 5 |
186.0 |
uV |
23.8 |
53.22 |
electroretinography |
cornea |
0.0 |
|
37 |
days |
control for age matched plasmid injection |
scotopic b-wave ERG |
108702 |
3131 |
| RCS-p+/LavRrrc |
photoreceptor inner segment thickness |
sham gene transfer using an empty plasmid vector pVAX2 (30 ug) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
photoreceptor inner segment morphology trait |
both |
51.0 days
| 5 |
6.4 |
um |
0.3 |
0.67 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
plasmid delivery |
35 |
days |
|
superior hemisphere - photoreceptor IS |
108712 |
3131 |
| RCS-p+/LavRrrc |
retinal outer nuclear layer thickness |
sham gene transfer using an empty plasmid vector pVAX2 (30 ug) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
retinal outer nuclear layer morphology trait |
both |
70.0 days
| 5 |
8.5 |
um |
0.7 |
1.57 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
plasmid delivery |
54 |
days |
|
superior hemisphere |
108718 |
3131 |
| RCS-p+/LavRrrc |
scotopic A wave amplitude of ERG waveform |
sham gene transfer using an empty plasmid vector pVAX2 (30 ug) then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
rod electrophysiology trait |
both |
53.0 days
| 5 |
60.2 |
uV |
8.5 |
19.01 |
electroretinography |
cornea |
0.0 |
plasmid delivery |
37 |
days |
|
scotopic a-wave ERG |
108726 |
3131 |
| RCS-p+/LavRrrc |
retinal inner layer thickness |
gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (15 ug) and gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (15 ug) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
retinal inner nuclear layer morphology trait |
both |
70.0 days
| 4 |
32.2 |
um |
1.6 |
3.2 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
plasmid delivery |
54 |
days |
pVAX2-rGDNF |
superior hemisphere |
108738 |
3131 |
| RCS-p+/LavRrrc |
photoreceptor inner segment thickness |
sham gene transfer using an empty plasmid vector pVAX2 (30 ug) and sham gene transfer using an empty plasmid vector pVAX2 (30 ug) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
photoreceptor inner segment morphology trait |
both |
70.0 days
| 4 |
9.2 |
um |
1.0 |
2.0 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
plasmid delivery |
54 |
days |
|
superior hemisphere |
108743 |
3131 |
| RCS-p+/LavRrrc |
scotopic A wave amplitude of ERG waveform |
gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (30 ug) and gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (30 ug) then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
rod electrophysiology trait |
both |
70.0 days
| 3 |
20.9 |
uV |
3.7 |
6.41 |
electroretinography |
cornea |
0.0 |
plasmid delivery |
54 |
days |
pVAX2-rGDNF |
scotopic a-wave ERG |
108748 |
3131 |
| RCS-p+/LavRrrc |
scotopic A wave amplitude of ERG waveform |
gene transfer of the enhanced green fluorescent protein gene using an adenovirus vector (5250000 PFU) then controlled exposure to darkness (for 12 hours) |
Tao Z, et al., Oncotarget. 2016 Aug 2;7(31):49368-49383. doi: 10.18632/oncotarget.10343. |
rod electrophysiology trait |
both |
62.0 days
| 5 |
9.7 |
uV |
9.9 |
22.14 |
electroretinography |
cornea |
0.0 |
subretinal injection |
42 |
days |
adenovirus |
a-wave amplitude ERG |
108387 |
3121 |
| RCS-p+/LavRrrc |
retinal outer nuclear layer photoreceptor nucleus count to layer length ratio |
control condition |
Kang S, et al., Transl Vis Sci Technol. 2019 Aug 7;8(4):19. doi: 10.1167/tvst.8.4.19. eCollection 2019 Jul. |
retinal photoreceptor quantity |
not specified |
180.0 days
| 8 |
3.3 |
/ 100 um |
2.8 |
7.92 |
ex vivo light microscopy with histochemistry |
|
0.0 |
|
|
|
|
|
109122 |
3082 |
| RCS-p+/LavRrrc |
retinal outer nuclear layer thickness |
light phase of controlled light/dark cycle (0-5 lux) (for 12 hours) |
Bubis E, et al., Transl Vis Sci Technol. 2019 Feb 28;8(1):26. doi: 10.1167/tvst.8.1.26. eCollection 2019 Jan. |
retinal photoreceptor layer morphology trait |
not specified |
56.0 days
| 15 |
0.0 |
um |
0.0 |
0.0 |
optical coherence tomography |
retina |
0.0 |
|
|
|
Heidelberg Spectralis SD-OCT |
|
110656 |
3181 |
| RCS-p+/LavRrrc |
retinal outer nuclear layer thickness |
light phase of controlled light/dark cycle (0-5 lux) (for 12 hours) |
Bubis E, et al., Transl Vis Sci Technol. 2019 Feb 28;8(1):26. doi: 10.1167/tvst.8.1.26. eCollection 2019 Jan. |
retinal photoreceptor layer morphology trait |
not specified |
70.0 days
| 12 |
0.0 |
um |
0.0 |
0.0 |
optical coherence tomography |
retina |
0.0 |
|
|
|
Heidelberg Spectralis SD-OCT |
|
110657 |
3181 |
| RCS-p+/LavRrrc |
full retina thickness |
light phase of controlled light/dark cycle (0-5 lux) (for 12 hours) |
Bubis E, et al., Transl Vis Sci Technol. 2019 Feb 28;8(1):26. doi: 10.1167/tvst.8.1.26. eCollection 2019 Jan. |
retinal layer morphology trait |
not specified |
84.0 days
| 9 |
150.7 |
um |
0.8 |
2.4 |
optical coherence tomography |
retina |
0.0 |
|
|
|
Heidelberg Spectralis SD-OCT |
|
110668 |
3181 |
| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
sham gene transfer using an empty plasmid vector pVAX2 (30 ug) then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
rod electrophysiology trait |
both |
53.0 days
| 5 |
352.0 |
uV |
26.0 |
58.14 |
electroretinography |
cornea |
0.0 |
plasmid delivery |
37 |
days |
|
scotopic b-wave ERG |
108728 |
3131 |
| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
2-methyl-6-(phenylethynyl)pyridine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2)) |
Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. |
rod electrophysiology trait |
both |
39.0 days
| 7 |
83.4 |
uV |
14.8 |
39.16 |
electroretinography |
cornea |
0.0 |
subretinal injection |
4 |
days |
pbs |
a wave amplitude ERG |
108543 |
3123 |
| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
2-methyl-6-(phenylethynyl)pyridine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2)) |
Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. |
rod electrophysiology trait |
both |
39.0 days
| 7 |
145.24 |
uV |
12.56 |
33.23 |
electroretinography |
cornea |
0.0 |
subretinal injection |
4 |
days |
pbs |
a wave amplitude ERG |
108544 |
3123 |
| RCS-p+/LavRrrc |
scotopic A wave amplitude of ERG waveform |
phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2)) |
Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. |
rod electrophysiology trait |
both |
39.0 days
| 7 |
31.22 |
uV |
8.16 |
21.59 |
electroretinography |
cornea |
0.0 |
subretinal injection |
4 |
days |
MPEP |
a-wave amplitude ERG |
108551 |
3123 |
| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2)) |
Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. |
rod electrophysiology trait |
both |
39.0 days
| 7 |
179.49 |
uV |
20.75 |
54.9 |
electroretinography |
cornea |
0.0 |
subretinal injection |
4 |
days |
pbs |
b-wave amplitude ERG |
108559 |
3123 |
| RCS-p+/LavRrrc |
photopic B wave amplitude of ERG waveform |
vehicle control condition (2 ul) then visible light stimulus (25 cd x s/m2) |
Baranov P, et al., J Ocul Pharmacol Ther. 2017 Jun;33(5):412-422. doi: 10.1089/jop.2016.0121. Epub 2017 Apr 25. |
cone electrophysiology trait |
not specified |
119.0 days
| 7 |
23.1 |
uV |
1.0 |
2.65 |
electroretinography |
cornea |
0.0 |
intravitrial injection |
98 |
days |
|
|
109739 |
3154 |
| RCS-p+/LavRrrc |
retinal outer nuclear layer photoreceptor nucleus count to layer length ratio |
laser photocoagulation (45 um) (for 0 hours) |
Kang S, et al., Transl Vis Sci Technol. 2019 Aug 7;8(4):19. doi: 10.1167/tvst.8.4.19. eCollection 2019 Jul. |
retinal photoreceptor quantity |
not specified |
180.0 days
| 5 |
16.2 |
/ 100 um |
5.5 |
12.3 |
ex vivo light microscopy with histochemistry |
|
0.0 |
photocoagulation |
161 |
days |
experimental eye |
|
107363 |
3082 |
| RCS-p+/LavRrrc |
retinal outer nuclear layer photoreceptor nucleus count to layer length ratio |
control condition |
Kang S, et al., Transl Vis Sci Technol. 2019 Aug 7;8(4):19. doi: 10.1167/tvst.8.4.19. eCollection 2019 Jul. |
retinal photoreceptor quantity |
not specified |
180.0 days
| 5 |
2.9 |
/ 100 um |
3.0 |
6.71 |
ex vivo light microscopy with histochemistry |
|
0.0 |
|
|
|
contralateral control eye |
|
107368 |
3082 |
| RCS-p+/LavRrrc |
scotopic A wave amplitude of ERG waveform |
gene transfer of the enhanced green fluorescent protein gene using an adenovirus vector (5250000 PFU) then controlled exposure to darkness (for 12 hours) |
Tao Z, et al., Oncotarget. 2016 Aug 2;7(31):49368-49383. doi: 10.18632/oncotarget.10343. |
rod electrophysiology trait |
both |
34.0 days
| 8 |
20.0 |
uV |
20.0 |
56.57 |
electroretinography |
cornea |
0.0 |
subretinal injection |
14 |
days |
adenovirus |
a-wave amplitude ERG |
108375 |
3121 |
| RCS-p+/LavRrrc |
retinal inner nuclear layer thickness |
sham gene transfer using an empty plasmid vector pVAX2 (30 ug) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
retinal inner nuclear layer morphology trait |
both |
75.0 days
| 5 |
29.9 |
um |
1.5 |
3.35 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
plasmid delivery |
55 |
days |
|
|
108697 |
3131 |
| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
control condition then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
rod electrophysiology trait |
both |
75.0 days
| 5 |
24.7 |
uV |
13.8 |
30.86 |
electroretinography |
cornea |
0.0 |
|
59 |
days |
control for age matched plasmid injection |
scotopic b-wave ERG |
108704 |
3131 |
| RCS-p+/LavRrrc |
retinal outer nuclear layer thickness |
gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (30 ug) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
retinal outer nuclear layer morphology trait |
both |
51.0 days
| 5 |
27.7 |
um |
1.1 |
2.46 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
plasmid delivery |
35 |
days |
pVAX2-rGDNF |
superior hemisphere |
108709 |
3131 |
| RCS-p+/LavRrrc |
photoreceptor inner segment thickness |
sham gene transfer using an empty plasmid vector pVAX2 (30 ug) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
photoreceptor inner segment morphology trait |
both |
70.0 days
| 5 |
0.9 |
um |
0.2 |
0.45 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
plasmid delivery |
54 |
days |
|
superior hemisphere - photoreceptor IS |
108716 |
3131 |
| RCS-p+/LavRrrc |
photoreceptor inner segment thickness |
gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (30 ug) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
photoreceptor inner segment morphology trait |
both |
70.0 days
| 5 |
1.8 |
um |
0.4 |
0.89 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
plasmid delivery |
54 |
days |
pVAX2-rGDNF |
superior hemisphere - photoreceptor IS |
108715 |
3131 |
| RCS-p+/LavRrrc |
photoreceptor inner segment thickness |
gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (30 ug) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
photoreceptor inner segment morphology trait |
both |
87.0 days
| 5 |
1.5 |
um |
0.4 |
0.89 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
plasmid delivery |
71 |
days |
pVAX2-rGDNF |
superior hemisphere - photoreceptor IS |
108723 |
3131 |
| RCS-p+/LavRrrc |
retinal outer nuclear layer thickness |
sham gene transfer using an empty plasmid vector pVAX2 (30 ug) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
retinal outer nuclear layer morphology trait |
both |
87.0 days
| 5 |
4.7 |
um |
0.7 |
1.57 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
plasmid delivery |
71 |
days |
|
superior hemisphere |
108722 |
3131 |
| RCS-p+/LavRrrc |
retinal outer nuclear layer thickness |
sham gene transfer using an empty plasmid vector pVAX2 (30 ug) and sham gene transfer using an empty plasmid vector pVAX2 (30 ug) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
retinal outer nuclear layer morphology trait |
both |
70.0 days
| 4 |
17.6 |
um |
1.7 |
3.4 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
plasmid delivery |
54 |
days |
|
superior hemisphere |
108740 |
3131 |
| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (15 ug) and gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (15 ug) then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
rod electrophysiology trait |
both |
70.0 days
| 3 |
199.0 |
uV |
17.0 |
29.44 |
electroretinography |
cornea |
0.0 |
plasmid delivery |
54 |
days |
pVAX2-rGDNF |
scotopic b-wave ERG |
108750 |
3131 |
| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
gene transfer of the enhanced green fluorescent protein gene using an adenovirus vector (5250000 PFU) then controlled exposure to darkness (for 12 hours) |
Tao Z, et al., Oncotarget. 2016 Aug 2;7(31):49368-49383. doi: 10.18632/oncotarget.10343. |
rod electrophysiology trait |
both |
34.0 days
| 8 |
39.0 |
uV |
23.0 |
65.05 |
electroretinography |
cornea |
0.0 |
subretinal injection |
14 |
days |
adenovirus |
b-wave amplitude ERG |
108378 |
3121 |
| RCS-p+/LavRrrc |
scotopic A wave amplitude of ERG waveform |
gene transfer of the lin-28 homolog B gene using an adenovirus vector (5250000 PFU) then controlled exposure to darkness (for 12 hours) |
Tao Z, et al., Oncotarget. 2016 Aug 2;7(31):49368-49383. doi: 10.18632/oncotarget.10343. |
rod electrophysiology trait |
both |
34.0 days
| 8 |
34.0 |
uV |
26.0 |
73.54 |
electroretinography |
cornea |
0.0 |
subretinal injection |
14 |
days |
adenovirus |
a-wave amplitude ERG |
108376 |
3121 |
| RCS-p+/LavRrrc |
scotopic A wave amplitude of ERG waveform |
gene transfer of the lin-28 homolog B gene using an adenovirus vector (5250000 PFU) then controlled exposure to darkness (for 12 hours) |
Tao Z, et al., Oncotarget. 2016 Aug 2;7(31):49368-49383. doi: 10.18632/oncotarget.10343. |
rod electrophysiology trait |
both |
48.0 days
| 5 |
27.0 |
uV |
22.0 |
49.19 |
electroretinography |
cornea |
0.0 |
subretinal injection |
28 |
days |
adenovirus |
a-wave amplitude ERG |
108382 |
3121 |
| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
control condition then controlled exposure to darkness (for 12 hours) |
Tao Z, et al., Oncotarget. 2016 Aug 2;7(31):49368-49383. doi: 10.18632/oncotarget.10343. |
rod electrophysiology trait |
both |
48.0 days
| 5 |
48.0 |
uV |
26.0 |
58.14 |
electroretinography |
|
0.0 |
|
|
|
untreated control |
b-wave amplitude ERG |
108383 |
3121 |
| RCS-p+/LavRrrc |
retinal outer nuclear layer thickness |
light phase of controlled light/dark cycle (0-5 lux) (for 12 hours) |
Bubis E, et al., Transl Vis Sci Technol. 2019 Feb 28;8(1):26. doi: 10.1167/tvst.8.1.26. eCollection 2019 Jan. |
retinal photoreceptor layer morphology trait |
not specified |
42.0 days
| 18 |
15.3 |
um |
0.7 |
2.97 |
optical coherence tomography |
retina |
0.0 |
|
|
|
Heidelberg Spectralis SD-OCT |
|
110655 |
3181 |
| RCS-p+/LavRrrc |
full retina thickness |
light phase of controlled light/dark cycle (0-5 lux) (for 12 hours) |
Bubis E, et al., Transl Vis Sci Technol. 2019 Feb 28;8(1):26. doi: 10.1167/tvst.8.1.26. eCollection 2019 Jan. |
retinal layer morphology trait |
not specified |
28.0 days
| 21 |
232.5 |
um |
2.8 |
12.83 |
optical coherence tomography |
retina |
0.0 |
|
|
|
Heidelberg Spectralis SD-OCT |
|
110664 |
3181 |
| RCS-p+/LavRrrc |
retinal inner layer thickness |
sham gene transfer using an empty plasmid vector pVAX2 (30 ug) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
retinal inner nuclear layer morphology trait |
both |
70.0 days
| 5 |
20.1 |
um |
0.6 |
1.34 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
plasmid delivery |
54 |
days |
|
superior hemisphere |
108714 |
3131 |
| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
sham gene transfer using an empty plasmid vector pVAX2 (30 ug) then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
rod electrophysiology trait |
both |
75.0 days
| 5 |
114.0 |
uV |
16.0 |
35.78 |
electroretinography |
cornea |
0.0 |
plasmid delivery |
59 |
days |
|
scotopic b-wave ERG |
108732 |
3131 |
| RCS-p+/LavRrrc |
scotopic A wave amplitude of ERG waveform |
sham gene transfer using an empty plasmid vector pVAX2 (30 ug) then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
rod electrophysiology trait |
both |
75.0 days
| 5 |
23.1 |
uV |
4.0 |
8.94 |
electroretinography |
cornea |
0.0 |
plasmid delivery |
59 |
days |
|
scotopic a-wave ERG |
108730 |
3131 |
| RCS-p+/LavRrrc |
scotopic A wave amplitude of ERG waveform |
2-methyl-6-(phenylethynyl)pyridine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2)) |
Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. |
rod electrophysiology trait |
both |
39.0 days
| 7 |
5.86 |
uV |
0.76 |
2.01 |
electroretinography |
cornea |
0.0 |
subretinal injection |
4 |
days |
MPEP |
a-wave amplitude ERG |
108536 |
3123 |
| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
2-methyl-6-(phenylethynyl)pyridine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2)) |
Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. |
rod electrophysiology trait |
both |
39.0 days
| 7 |
7.44 |
uV |
1.43 |
3.78 |
electroretinography |
cornea |
0.0 |
subretinal injection |
4 |
days |
pbs |
a wave amplitude ERG |
108542 |
3123 |
| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2)) |
Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. |
rod electrophysiology trait |
both |
39.0 days
| 7 |
94.13 |
uV |
15.33 |
40.56 |
electroretinography |
cornea |
0.0 |
subretinal injection |
4 |
days |
pbs |
b-wave amplitude ERG |
108556 |
3123 |
| RCS-p+/LavRrrc |
scotopic A wave amplitude of ERG waveform |
gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (30 ug) then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
rod electrophysiology trait |
both |
87.0 days
| 5 |
17.1 |
uV |
3.2 |
7.16 |
electroretinography |
cornea |
0.0 |
plasmid delivery |
71 |
days |
pVAX2-rGDNF |
scotopic a-wave ERG |
108733 |
3131 |
| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
sham gene transfer using an empty plasmid vector pVAX2 (30 ug) then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
rod electrophysiology trait |
both |
87.0 days
| 5 |
110.0 |
uV |
14.0 |
31.3 |
electroretinography |
cornea |
0.0 |
plasmid delivery |
71 |
days |
|
scotopic b-wave ERG |
108736 |
3131 |
| RCS-p+/LavRrrc |
optokinetic reflex |
GSK-812 (2 ul) then visible light stimulus (25 cd x s/m2) |
Baranov P, et al., J Ocul Pharmacol Ther. 2017 Jun;33(5):412-422. doi: 10.1089/jop.2016.0121. Epub 2017 Apr 25. |
eye physiology trait |
not specified |
119.0 days
| 7 |
8.2 |
s |
0.4 |
1.06 |
optokinetic reflex test method |
|
60.0 |
intravitrial injection |
98 |
days |
|
|
109742 |
3154 |
| RCS-p+/LavRrrc |
retinal outer nuclear layer photoreceptor nucleus count to layer length ratio |
laser photocoagulation (180 um) (for 0 hours) |
Kang S, et al., Transl Vis Sci Technol. 2019 Aug 7;8(4):19. doi: 10.1167/tvst.8.4.19. eCollection 2019 Jul. |
retinal photoreceptor quantity |
not specified |
180.0 days
| 5 |
2.5 |
/ 100 um |
1.5 |
3.35 |
ex vivo light microscopy with histochemistry |
|
0.0 |
photocoagulation |
161 |
days |
experimental eye |
|
107369 |
3082 |
| RCS-p+/LavRrrc |
retinal outer nuclear layer photoreceptor nucleus count to layer length ratio |
laser photocoagulation (67.5 um) (for 0 hours) |
Kang S, et al., Transl Vis Sci Technol. 2019 Aug 7;8(4):19. doi: 10.1167/tvst.8.4.19. eCollection 2019 Jul. |
retinal photoreceptor quantity |
not specified |
180.0 days
| 5 |
30.8 |
/ 100 um |
14.3 |
31.98 |
ex vivo light microscopy with histochemistry |
|
0.0 |
photocoagulation |
161 |
days |
experimental eye |
|
107365 |
3082 |
| RCS-p+/LavRrrc |
scotopic A wave amplitude of ERG waveform |
gene transfer of the lin-28 homolog B gene using an adenovirus vector (5250000 PFU) then controlled exposure to darkness (for 12 hours) |
Tao Z, et al., Oncotarget. 2016 Aug 2;7(31):49368-49383. doi: 10.18632/oncotarget.10343. |
rod electrophysiology trait |
both |
62.0 days
| 5 |
11.0 |
uV |
12.0 |
26.83 |
electroretinography |
cornea |
0.0 |
subretinal injection |
42 |
days |
adenovirus |
a-wave amplitude ERG |
108388 |
3121 |
| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
gene transfer of the lin-28 homolog B gene using an adenovirus vector (5250000 PFU) then controlled exposure to darkness (for 12 hours) |
Tao Z, et al., Oncotarget. 2016 Aug 2;7(31):49368-49383. doi: 10.18632/oncotarget.10343. |
rod electrophysiology trait |
both |
62.0 days
| 5 |
34.0 |
uV |
27.0 |
60.37 |
electroretinography |
cornea |
0.0 |
subretinal injection |
42 |
days |
adenovirus |
b-wave amplitude ERG |
108391 |
3121 |
| RCS-p+/LavRrrc |
retinal outer nuclear layer thickness |
gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (30 ug) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
retinal outer nuclear layer morphology trait |
both |
87.0 days
| 5 |
5.4 |
um |
0.6 |
1.34 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
plasmid delivery |
71 |
days |
pVAX2-rGDNF |
superior hemisphere |
108721 |
3131 |
| RCS-p+/LavRrrc |
photoreceptor inner segment thickness |
sham gene transfer using an empty plasmid vector pVAX2 (30 ug) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
photoreceptor inner segment morphology trait |
both |
87.0 days
| 5 |
1.1 |
um |
0.5 |
1.12 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
plasmid delivery |
71 |
days |
|
superior hemisphere - photoreceptor IS |
108724 |
3131 |
| RCS-p+/LavRrrc |
scotopic A wave amplitude of ERG waveform |
gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (30 ug) then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
rod electrophysiology trait |
both |
53.0 days
| 5 |
96.3 |
uV |
10.3 |
23.03 |
electroretinography |
cornea |
0.0 |
plasmid delivery |
37 |
days |
pVAX2-rGDNF |
scotopic a-wave ERG |
108725 |
3131 |
| RCS-p+/LavRrrc |
retinal inner layer thickness |
sham gene transfer using an empty plasmid vector pVAX2 (30 ug) and sham gene transfer using an empty plasmid vector pVAX2 (30 ug) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
retinal inner nuclear layer morphology trait |
both |
70.0 days
| 4 |
30.5 |
um |
1.3 |
2.6 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
plasmid delivery |
54 |
days |
|
superior hemisphere |
108737 |
3131 |
| RCS-p+/LavRrrc |
retinal outer nuclear layer thickness |
gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (15 ug) and gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (15 ug) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
retinal outer nuclear layer morphology trait |
both |
70.0 days
| 4 |
16.8 |
um |
1.9 |
3.8 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
plasmid delivery |
54 |
days |
pVAX2-rGDNF |
superior hemisphere |
108741 |
3131 |
| RCS-p+/LavRrrc |
scotopic A wave amplitude of ERG waveform |
sham gene transfer using an empty plasmid vector pVAX2 (30 ug) and sham gene transfer using an empty plasmid vector pVAX2 (30 ug) then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
rod electrophysiology trait |
both |
70.0 days
| 3 |
23.8 |
uV |
1.9 |
3.29 |
electroretinography |
cornea |
0.0 |
plasmid delivery |
54 |
days |
pVAX2 |
scotopic a-wave ERG |
108746 |
3131 |
| RCS-p+/LavRrrc |
retinal outer nuclear layer thickness |
light phase of controlled light/dark cycle (0-5 lux) (for 12 hours) |
Bubis E, et al., Transl Vis Sci Technol. 2019 Feb 28;8(1):26. doi: 10.1167/tvst.8.1.26. eCollection 2019 Jan. |
retinal photoreceptor layer morphology trait |
not specified |
84.0 days
| 9 |
0.0 |
um |
0.0 |
0.0 |
optical coherence tomography |
retina |
0.0 |
|
|
|
Heidelberg Spectralis SD-OCT |
|
110658 |
3181 |
| RCS-p+/LavRrrc |
debris zone thickness |
light phase of controlled light/dark cycle (0-5 lux) (for 12 hours) |
Bubis E, et al., Transl Vis Sci Technol. 2019 Feb 28;8(1):26. doi: 10.1167/tvst.8.1.26. eCollection 2019 Jan. |
retinal photoreceptor layer morphology trait |
not specified |
70.0 days
| 12 |
28.6 |
um |
1.0 |
3.46 |
optical coherence tomography |
retina |
0.0 |
|
|
|
Heidelberg Spectralis SD-OCT |
|
110662 |
3181 |
| RCS-p+/LavRrrc |
debris zone thickness |
light phase of controlled light/dark cycle (0-5 lux) (for 12 hours) |
Bubis E, et al., Transl Vis Sci Technol. 2019 Feb 28;8(1):26. doi: 10.1167/tvst.8.1.26. eCollection 2019 Jan. |
retinal photoreceptor layer morphology trait |
not specified |
84.0 days
| 9 |
15.66 |
um |
1.6 |
4.8 |
optical coherence tomography |
retina |
0.0 |
|
|
|
Heidelberg Spectralis SD-OCT |
debris zone |
110663 |
3181 |
| RCS-p+/LavRrrc |
full retina thickness |
light phase of controlled light/dark cycle (0-5 lux) (for 12 hours) |
Bubis E, et al., Transl Vis Sci Technol. 2019 Feb 28;8(1):26. doi: 10.1167/tvst.8.1.26. eCollection 2019 Jan. |
retinal layer morphology trait |
not specified |
56.0 days
| 15 |
175.8 |
um |
1.5 |
5.81 |
optical coherence tomography |
retina |
0.0 |
|
|
|
Heidelberg Spectralis SD-OCT |
|
110666 |
3181 |
| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (30 ug) then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
rod electrophysiology trait |
both |
75.0 days
| 5 |
135.0 |
uV |
38.0 |
84.97 |
electroretinography |
cornea |
0.0 |
plasmid delivery |
59 |
days |
pVAX2-rGDNF |
scotopic b-wave ERG |
108731 |
3131 |
| RCS-p+/LavRrrc |
scotopic A wave amplitude of ERG waveform |
2-methyl-6-(phenylethynyl)pyridine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2)) |
Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. |
rod electrophysiology trait |
both |
39.0 days
| 7 |
18.53 |
uV |
4.77 |
12.63 |
electroretinography |
cornea |
0.0 |
subretinal injection |
4 |
days |
MPEP |
a-wave amplitude ERG |
108538 |
3123 |
| RCS-p+/LavRrrc |
scotopic A wave amplitude of ERG waveform |
2-methyl-6-(phenylethynyl)pyridine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2)) |
Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. |
rod electrophysiology trait |
both |
39.0 days
| 7 |
36.49 |
uV |
10.37 |
27.44 |
electroretinography |
cornea |
0.0 |
subretinal injection |
4 |
days |
MPEP |
a-wave amplitude ERG |
108541 |
3123 |
| RCS-p+/LavRrrc |
scotopic A wave amplitude of ERG waveform |
phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2)) |
Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. |
rod electrophysiology trait |
both |
39.0 days
| 7 |
3.13 |
uV |
1.81 |
4.79 |
electroretinography |
cornea |
0.0 |
subretinal injection |
4 |
days |
MPEP |
a-wave amplitude ERG |
108548 |
3123 |
| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
2-methyl-6-(phenylethynyl)pyridine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2)) |
Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. |
rod electrophysiology trait |
both |
39.0 days
| 7 |
251.29 |
uV |
19.14 |
50.64 |
electroretinography |
cornea |
0.0 |
subretinal injection |
4 |
days |
pbs |
a wave amplitude ERG |
108547 |
3123 |
| RCS-p+/LavRrrc |
scotopic A wave amplitude of ERG waveform |
phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2)) |
Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. |
rod electrophysiology trait |
both |
39.0 days
| 7 |
24.79 |
uV |
7.82 |
20.69 |
electroretinography |
cornea |
0.0 |
subretinal injection |
4 |
days |
MPEP |
a-wave amplitude ERG |
108552 |
3123 |
| RCS-p+/LavRrrc |
scotopic A wave amplitude of ERG waveform |
phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2)) |
Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. |
rod electrophysiology trait |
both |
39.0 days
| 7 |
31.96 |
uV |
9.73 |
25.74 |
electroretinography |
cornea |
0.0 |
subretinal injection |
4 |
days |
MPEP |
a-wave amplitude ERG |
108553 |
3123 |
| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2)) |
Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. |
rod electrophysiology trait |
both |
39.0 days
| 7 |
10.28 |
uV |
1.69 |
4.47 |
electroretinography |
cornea |
0.0 |
subretinal injection |
4 |
days |
pbs |
b-wave amplitude ERG |
108554 |
3123 |
| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2)) |
Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. |
rod electrophysiology trait |
both |
39.0 days
| 7 |
32.75 |
uV |
13.42 |
35.51 |
electroretinography |
cornea |
0.0 |
subretinal injection |
4 |
days |
pbs |
b-wave amplitude ERG |
108555 |
3123 |
| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2)) |
Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. |
rod electrophysiology trait |
both |
39.0 days
| 7 |
131.7 |
uV |
16.13 |
42.68 |
electroretinography |
cornea |
0.0 |
subretinal injection |
4 |
days |
pbs |
b-wave amplitude ERG |
108557 |
3123 |
| RCS-p+/LavRrrc |
photopic B wave amplitude of ERG waveform |
GSK-812 (2 ul) then visible light stimulus (25 cd x s/m2) |
Baranov P, et al., J Ocul Pharmacol Ther. 2017 Jun;33(5):412-422. doi: 10.1089/jop.2016.0121. Epub 2017 Apr 25. |
cone electrophysiology trait |
not specified |
119.0 days
| 7 |
28.9 |
uV |
2.5 |
6.61 |
electroretinography |
cornea |
0.0 |
intravitrial injection |
98 |
days |
|
|
109740 |
3154 |
| RCS-p+/LavRrrc |
optokinetic reflex |
vehicle control condition (2 ul) then visible light stimulus (25 cd x s/m2) |
Baranov P, et al., J Ocul Pharmacol Ther. 2017 Jun;33(5):412-422. doi: 10.1089/jop.2016.0121. Epub 2017 Apr 25. |
eye physiology trait |
not specified |
119.0 days
| 7 |
6.0 |
s |
0.27 |
0.71 |
optokinetic reflex test method |
|
60.0 |
intravitrial injection |
98 |
days |
|
|
109741 |
3154 |
| RCS-p+/LavRrrc |
retinal outer nuclear layer photoreceptor nucleus count to layer length ratio |
laser photocoagulation (22.5 um) (for 0 hours) |
Kang S, et al., Transl Vis Sci Technol. 2019 Aug 7;8(4):19. doi: 10.1167/tvst.8.4.19. eCollection 2019 Jul. |
retinal photoreceptor quantity |
not specified |
180.0 days
| 5 |
17.2 |
/ 100 um |
5.4 |
12.07 |
ex vivo light microscopy with histochemistry |
|
0.0 |
photocoagulation |
161 |
days |
experimental eye |
|
107361 |
3082 |
| RCS-p+/LavRrrc |
retinal outer nuclear layer photoreceptor nucleus count to layer length ratio |
laser photocoagulation (135 um) (for 0 hours) |
Kang S, et al., Transl Vis Sci Technol. 2019 Aug 7;8(4):19. doi: 10.1167/tvst.8.4.19. eCollection 2019 Jul. |
retinal photoreceptor quantity |
not specified |
180.0 days
| 5 |
3.1 |
/ 100 um |
2.3 |
5.14 |
ex vivo light microscopy with histochemistry |
|
0.0 |
photocoagulation |
161 |
days |
experimental eye |
|
107367 |
3082 |
| RCS-p+/LavRrrc |
retinal outer nuclear layer photoreceptor nucleus count to layer length ratio |
control condition |
Kang S, et al., Transl Vis Sci Technol. 2019 Aug 7;8(4):19. doi: 10.1167/tvst.8.4.19. eCollection 2019 Jul. |
retinal photoreceptor quantity |
not specified |
180.0 days
| 5 |
3.4 |
/ 100 um |
3.7 |
8.27 |
ex vivo light microscopy with histochemistry |
|
0.0 |
|
|
|
contralateral control eye |
|
107366 |
3082 |
| RCS-p+/LavRrrc |
scotopic A wave amplitude of ERG waveform |
control condition then controlled exposure to darkness (for 12 hours) |
Tao Z, et al., Oncotarget. 2016 Aug 2;7(31):49368-49383. doi: 10.18632/oncotarget.10343. |
rod electrophysiology trait |
both |
62.0 days
| 5 |
8.9 |
uV |
9.9 |
22.14 |
electroretinography |
|
0.0 |
|
|
|
untreated control |
a-wave amplitude ERG |
108386 |
3121 |
| RCS-p+/LavRrrc |
retinal outer nuclear layer thickness |
control condition |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
retinal outer nuclear layer morphology trait |
both |
75.0 days
| 3 |
8.1 |
um |
1.2 |
2.08 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
55 |
days |
control for age matched plasmid injection |
|
108700 |
3131 |
| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
sham gene transfer using an empty plasmid vector pVAX2 (30 ug) then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
rod electrophysiology trait |
both |
75.0 days
| 5 |
114.0 |
uV |
16.1 |
36.0 |
electroretinography |
cornea |
0.0 |
plasmid delivery |
59 |
days |
|
scotopic b-wave ERG |
108703 |
3131 |
| RCS-p+/LavRrrc |
retinal outer nuclear layer thickness |
sham gene transfer using an empty plasmid vector pVAX2 (30 ug) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
retinal outer nuclear layer morphology trait |
both |
51.0 days
| 5 |
22.2 |
um |
0.9 |
2.01 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
plasmid delivery |
35 |
days |
|
superior hemisphere |
108710 |
3131 |
| RCS-p+/LavRrrc |
retinal inner layer thickness |
gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (30 ug) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
retinal inner nuclear layer morphology trait |
both |
70.0 days
| 5 |
27.4 |
um |
0.6 |
1.34 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
plasmid delivery |
54 |
days |
pVAX2-rGDNF |
superior hemisphere |
108713 |
3131 |
| RCS-p+/LavRrrc |
retinal inner layer thickness |
sham gene transfer using an empty plasmid vector pVAX2 (30 ug) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
retinal inner nuclear layer morphology trait |
both |
87.0 days
| 5 |
20.8 |
um |
0.9 |
2.01 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
plasmid delivery |
71 |
days |
|
superior hemisphere |
108720 |
3131 |
| RCS-p+/LavRrrc |
retinal outer nuclear layer thickness |
gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (30 ug) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
retinal outer nuclear layer morphology trait |
both |
70.0 days
| 5 |
9.4 |
um |
1.0 |
2.24 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
plasmid delivery |
54 |
days |
pVAX2-rGDNF |
superior hemisphere |
108717 |
3131 |
| RCS-p+/LavRrrc |
retinal inner layer thickness |
gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (30 ug) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
retinal inner nuclear layer morphology trait |
both |
87.0 days
| 5 |
21.4 |
um |
0.7 |
1.57 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
plasmid delivery |
71 |
days |
pVAX2-rGDNF |
superior hemisphere |
108719 |
3131 |
| RCS-p+/LavRrrc |
scotopic A wave amplitude of ERG waveform |
gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (30 ug) then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
rod electrophysiology trait |
both |
75.0 days
| 5 |
29.7 |
uV |
11.3 |
25.27 |
electroretinography |
cornea |
0.0 |
plasmid delivery |
59 |
days |
pVAX2-rGDNF |
scotopic a-wave ERG |
108729 |
3131 |
| RCS-p+/LavRrrc |
retinal inner layer thickness |
gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (30 ug) and gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (30 ug) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
retinal inner nuclear layer morphology trait |
both |
70.0 days
| 4 |
28.3 |
um |
1.3 |
2.6 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
plasmid delivery |
54 |
days |
pVAX2-rGDNF |
superior hemisphere |
108739 |
3131 |
| RCS-p+/LavRrrc |
retinal outer nuclear layer thickness |
gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (30 ug) and gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (30 ug) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
retinal outer nuclear layer morphology trait |
both |
70.0 days
| 4 |
10.6 |
um |
1.7 |
3.4 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
plasmid delivery |
54 |
days |
pVAX2-rGDNF |
superior hemisphere |
108742 |
3131 |
| RCS-p+/LavRrrc |
photoreceptor inner segment thickness |
gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (30 ug) and gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (30 ug) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
photoreceptor inner segment morphology trait |
both |
70.0 days
| 4 |
5.2 |
um |
1.2 |
2.4 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
plasmid delivery |
54 |
days |
pVAX2-rGDNF |
superior hemisphere |
108745 |
3131 |
| RCS-p+/LavRrrc |
scotopic A wave amplitude of ERG waveform |
gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (15 ug) and gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (15 ug) then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
rod electrophysiology trait |
both |
70.0 days
| 3 |
26.7 |
uV |
2.7 |
4.68 |
electroretinography |
cornea |
0.0 |
plasmid delivery |
54 |
days |
pVAX2-rGDNF |
scotopic a-wave ERG |
108747 |
3131 |
| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (30 ug) and gene transfer of the rat GDNF gene using the plasmid vector pVAX2 (30 ug) then controlled exposure to darkness (for 1 days) then visible light stimulus (3 cd x s/m2) |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
rod electrophysiology trait |
both |
70.0 days
| 3 |
144.0 |
uV |
29.0 |
50.23 |
electroretinography |
cornea |
0.0 |
plasmid delivery |
54 |
days |
pVAX2-rGDNF |
scotopic b-wave ERG |
108751 |
3131 |
| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
gene transfer of the lin-28 homolog B gene using an adenovirus vector (5250000 PFU) then controlled exposure to darkness (for 12 hours) |
Tao Z, et al., Oncotarget. 2016 Aug 2;7(31):49368-49383. doi: 10.18632/oncotarget.10343. |
rod electrophysiology trait |
both |
34.0 days
| 8 |
79.0 |
uV |
43.0 |
121.62 |
electroretinography |
cornea |
0.0 |
subretinal injection |
14 |
days |
adenovirus |
b-wave amplitude ERG |
108379 |
3121 |
| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
gene transfer of the lin-28 homolog B gene using an adenovirus vector (5250000 PFU) then controlled exposure to darkness (for 12 hours) |
Tao Z, et al., Oncotarget. 2016 Aug 2;7(31):49368-49383. doi: 10.18632/oncotarget.10343. |
rod electrophysiology trait |
both |
48.0 days
| 5 |
110.0 |
uV |
40.0 |
89.44 |
electroretinography |
cornea |
0.0 |
subretinal injection |
28 |
days |
adenovirus |
b-wave amplitude ERG |
108385 |
3121 |
| RCS-p+/LavRrrc |
retinal outer nuclear layer photoreceptor nucleus count to layer length ratio |
subthreshold laser therapy (200 um) (for 0 hours) |
Kang S, et al., Transl Vis Sci Technol. 2019 Aug 7;8(4):19. doi: 10.1167/tvst.8.4.19. eCollection 2019 Jul. |
retinal photoreceptor quantity |
not specified |
180.0 days
| 8 |
3.0 |
/ 100 um |
2.5 |
7.07 |
ex vivo light microscopy with histochemistry |
|
0.0 |
SRT |
161 |
days |
experimental eye |
|
109067 |
3082 |
| RCS-p+/LavRrrc |
retinal outer nuclear layer photoreceptor nucleus count to layer length ratio |
control condition |
Kang S, et al., Transl Vis Sci Technol. 2019 Aug 7;8(4):19. doi: 10.1167/tvst.8.4.19. eCollection 2019 Jul. |
retinal photoreceptor quantity |
not specified |
180.0 days
| 8 |
2.3 |
/ 100 um |
1.3 |
3.68 |
ex vivo light microscopy with histochemistry |
|
0.0 |
|
|
|
contralateral control eye |
|
109068 |
3082 |
| RCS-p+/LavRrrc |
retinal outer nuclear layer photoreceptor nucleus count to layer length ratio |
nondamaging retinal laser therapy (50 um) (for 0 hours) |
Kang S, et al., Transl Vis Sci Technol. 2019 Aug 7;8(4):19. doi: 10.1167/tvst.8.4.19. eCollection 2019 Jul. |
retinal photoreceptor quantity |
not specified |
180.0 days
| 8 |
2.7 |
/ 100 um |
2.0 |
5.66 |
ex vivo light microscopy with histochemistry |
|
0.0 |
NRT |
161 |
days |
experimental eye |
|
109069 |
3082 |
| RCS-p+/LavRrrc |
retinal outer nuclear layer thickness |
light phase of controlled light/dark cycle (0-5 lux) (for 12 hours) |
Bubis E, et al., Transl Vis Sci Technol. 2019 Feb 28;8(1):26. doi: 10.1167/tvst.8.1.26. eCollection 2019 Jan. |
retinal photoreceptor layer morphology trait |
not specified |
28.0 days
| 21 |
50.5 |
um |
0.8 |
3.67 |
optical coherence tomography |
retina |
0.0 |
|
|
|
Heidelberg Spectralis SD-OCT |
|
110654 |
3181 |
| RCS-p+/LavRrrc |
debris zone thickness |
light phase of controlled light/dark cycle (0-5 lux) (for 12 hours) |
Bubis E, et al., Transl Vis Sci Technol. 2019 Feb 28;8(1):26. doi: 10.1167/tvst.8.1.26. eCollection 2019 Jan. |
retinal photoreceptor layer morphology trait |
not specified |
28.0 days
| 21 |
51.7 |
um |
0.8 |
3.67 |
optical coherence tomography |
retina |
0.0 |
|
|
|
Heidelberg Spectralis SD-OCT |
debris zone |
110659 |
3181 |
| RCS-p+/LavRrrc |
full retina thickness |
light phase of controlled light/dark cycle (0-5 lux) (for 12 hours) |
Bubis E, et al., Transl Vis Sci Technol. 2019 Feb 28;8(1):26. doi: 10.1167/tvst.8.1.26. eCollection 2019 Jan. |
retinal layer morphology trait |
not specified |
42.0 days
| 18 |
193.6 |
um |
1.7 |
7.21 |
optical coherence tomography |
retina |
0.0 |
|
|
|
Heidelberg Spectralis SD-OCT |
|
110665 |
3181 |
| RCS-p+/LavRrrc |
scotopic A wave amplitude of ERG waveform |
2-methyl-6-(phenylethynyl)pyridine (200 umol) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2)) |
Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. |
rod electrophysiology trait |
both |
39.0 days
| 7 |
27.22 |
uV |
4.74 |
12.54 |
electroretinography |
cornea |
0.0 |
subretinal injection |
4 |
days |
MPEP |
a-wave amplitude ERG |
108539 |
3123 |
| RCS-p+/LavRrrc |
scotopic A wave amplitude of ERG waveform |
phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2)) |
Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. |
rod electrophysiology trait |
both |
39.0 days
| 7 |
15.31 |
uV |
2.98 |
7.88 |
electroretinography |
cornea |
0.0 |
subretinal injection |
4 |
days |
MPEP |
a-wave amplitude ERG |
108549 |
3123 |